A SMAP in the face for cancer

The Journal of Clinical Investigation
Shirish Shenolikar

Abstract

Observed deficits in protein phosphatase 2A (PP2A) function in a variety of human cancers have stimulated drug discovery efforts aimed at restoring PP2A function to inhibit tumor growth. Work published by Sangodkar et al. in this issue of the JCI describes the characterization of orally available small molecule activators of PP2A (SMAPs). These SMAPs attenuated mitogenic signaling and triggered apoptosis in KRAS-mutant lung cancer cells and inhibited tumor growth in murine models. Tumors with mutations in the SMAP-binding site of the PP2A A subunit displayed resistance to SMAPs. Future studies that identify the PP2A-regulated events targeted by SMAPs should guide critical decisions about which cancers might be best treated with these molecules. This study provides encouraging evidence in favor of SMAPs as potential anticancer drugs.

References

Aug 1, 1986·European Journal of Cancer & Clinical Oncology·W ScheithauerE F Elslager
Sep 1, 1981·Computer Programs in Biomedicine·E R Powsner
Mar 1, 1994·Toxicon : Official Journal of the International Society on Toxinology·R E HonkanenR E Honkanan
Jun 2, 2007·Cell·Anna A SablinaWilliam C Hahn
Jan 25, 2008·Cancer Metastasis Reviews·Anna A Sablina, William C Hahn
Sep 4, 2013·The Journal of Clinical Investigation·Paolo NevianiDanilo Perrotti
Jan 10, 2014·The Journal of Clinical Investigation·Alejandro GutierrezJon C Aster
Jan 30, 2015·Journal of Virology·Hyun Jin KwunPatrick S Moore
May 2, 2015·The Journal of Clinical Investigation·Stefan GrossKlaus P Hoeflich
Oct 29, 2015·The FEBS Journal·Jaya SangodkarGoutham Narla
Sep 28, 2016·Cancer Research·Amanpreet KaurJukka Westermarck
May 16, 2017·The Journal of Clinical Investigation·Jaya SangodkarGoutham Narla

❮ Previous
Next ❯

Citations

Feb 6, 2019·The Journal of Clinical Investigation·Shaikamjad UmesalmaDawn E Quelle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.